LiveCharts vs Agado Evaluation
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
LiveCharts
This app allows users to connect with and monitor Halo devices, displaying vital signs like a hospital bedside monitor. It enables remote monitoring by medical professionals and provides detailed patient information and customizable graphs.
- Connect and control Halo devices
- Simultaneous multi-patient monitoring
- Hospital bedside monitor-style display
- Detailed patient information
- Configurable vital sign graphs
- Remote monitoring via Command Cloud
Read full descriptionHide full description
LiveCharts connects with and controls your Halo devices. The Dashboard allows you to simultaneously monitor multiple patients. Vital signs are displayed clearly across the screen in a format similar to that of a hospital bedside monitor called a Patient Card. Double-clicking on a Patient Card brings you to the Patient Details where you can view all of the information coming from the Halo device. Patients are prioritized by a severity level calculated from the value difference from each enabled alarm threshold while graphs are shown in configurable time periods with a 60-second default. LiveCharts communicates with the Command Cloud platform, allowing remote medical professionals to monitor patients’ vital signs data. Always seek a doctor’s advice in addition to using this app before making any medical decisions. The Sempulse Halo Platform has been cleared by the FDA for use in the United States and all countries that accept FDA clearances in their jurisdiction.
Agado Evaluation
This physiotherapy app guides users through home-based evaluations and personalized exercise recommendations for neurologic patients, particularly those with Parkinson's disease. It helps users track progress, understand their condition, and communicate with their therapist for enhanced well-being and an active life.
- Guided home evaluations
- Personalized exercise recommendations
- Progress tracking
- Detailed condition insights
- Therapist communication
Read full descriptionHide full description
Agado Live is a groundbreaking physiotherapy app specifically designed for neurologic patients, with a focus on those with Parkinson’s disease. It empowers you to take control of your rehabilitation journey from the comfort of your home. With Agado Live, you can perform guided evaluations, track your progress, and gain a comprehensive understanding of your physical condition. Based on your evaluation, the app will recommend personalized exercises to help prevent deterioration and enhance your well-being while practicing and improving. With Agado Live, you can: Perform evaluations at home: Easily assess your physical abilities and monitor your progress over time. Understand your condition: Receive detailed insights into your physical status, empowering you to make informed decisions about your care. Practice effectively: Get personalized exercise recommendations to maintain and improve your health. Stay connected: Communicate seamlessly with your therapist and get the guidance you need, whenever you need it. Take control of your well-being with Agado Live and experience a healthier, more active life.
Screenshots
Verdict
LiveCharts and Agado Evaluation are too close to call on the numbers: across 9 compared parameters — price, rating, ratings volume and update cadence among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for LiveCharts against 5.0 for Agado Evaluation. Both are backed by a comparable volume of ratings — 1 and 1 respectively.
LiveCharts ships an update every 3 weeks, Agado Evaluation monthly. The most recent releases landed on October 20, 2026 and October 13, 2026 respectively.
| Parameter | LiveCharts | Agado Evaluation |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) | 5.0 (1 ratings) |
| Number of ratings | 1 | 1 |
| Update frequency | Every 3 weeks — better | Monthly |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad | iPhone, iPad |
| Requires iOS | 16.0 | 16.0 |
| Further details — not scored | ||
| Size | 26 MB | 144 MB |
| Age rating | 12+ | 17+ |
| Developer | Sempulse Corporation | Agado |
Customer experience
LiveCharts
Agado Evaluation
In-app purchases
LiveCharts
No in-app purchases
Agado Evaluation
No in-app purchases









